Rapid Micro Biosystems, Inc.RPIDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +29.68% | +28.41% | +9.73% | +3.08% | +37.28% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +265.76% | +23.24% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +1.46% | +1.73% | +2.37% | +1.98% | +1.94% |
| Weighted Average Shares Diluted Growth | +1.46% | +1.73% | +2.37% | +1.98% | +1.94% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +34.78% | -15.35% | +15.89% | +31.10% | -58.35% |
| Inventory Growth | +1.20% | +1.49% | -4.06% | -0.87% | -12.91% |
| Asset Growth | -31.57% | -33.11% | -35.44% | -20.25% | -23.75% |
| Book Value per Share Growth | -37.05% | -39.23% | -43.67% | -48.48% | -56.77% |
| Debt Growth | -16.04% | -16.88% | -17.82% | +273.52% | +287.06% |
| R&D Expense Growth | +2.53% | -5.67% | -13.73% | -2.22% | -5.32% |
| SG&A Expenses Growth | -10.23% | -5.24% | -2.67% | -5.67% | +10.94% |